Cadila extends tenure of joint venture with Bayer Pte
Drug firm Cadila Healthcare on Wednesday said it has inked a pact to extend the tenure of a joint venture with Bayer Pte ltd for two months to explore possibilities of further collaboration. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2021 Category: Pharmaceuticals Source Type: news

Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatment
The antibody cocktail is to be administered for the treatment of mild to moderate coronavirus disease in adults and pediatric patients (12 years of age or older, weighing at least 40 kg) who are confirmed to be infected with SARS-COV2 and who are at high risk of developing severe COVID-19 disease, the statement said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2021 Category: Pharmaceuticals Source Type: news

I never saw any report which said numbers will go very high: Biotech Secy
"The B.1.167 (Indian) variant is prevalent in Maharashtra and we are seeing it now growing and increasing in other states like Delhi and Karnataka." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2021 Category: Pharmaceuticals Source Type: news

India reaches out to US companies over investment in pharmaceutical, medical devices sector
India's Ambassador to the US Taranjit Singh Sandhu has held virtual meetings with Alberta Bourla, the CEO of Pfizer, Thermo Fisher CEO Marc Casper, Bernd Brust, the chairman and CEO of Antylia Scientific, and Joseph Repp, the CEO of Pall Life Sciences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2021 Category: Pharmaceuticals Source Type: news

Hikal inks 10-year multi-product deal with global pharma company for APIs
The company has signed a multi-year contract with a leading global pharmaceutical company. This contract entails the development and supply of a portfolio of niche APIs over a period of 10 years, Hikal said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2021 Category: Pharmaceuticals Source Type: news

Serum Institute to invest 240 million pounds in UK; leads cross-sector Indian investments
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Explainer: Why those needing their second vaccine dose may have to wait
The vaccine shortage has raised concerns that some may not get their second dose on time. Slots are getting filled within minutes of opening and some states are even prioritising the 18-44 year group. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Remdesivir production increased to 1.05 cr vials a month: Mansukh Mandaviya
The production capacity of the drug has crossed 1.05 crore vials per month as on May 4, a nearly three-fold increase from 37 lakh vials per month on April 12 this year, Mandaviya said in a tweet. The minister said the antiviral drug is now being produced across 57 plants in the country compared to 20 facilities a month ago. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Bajaj Healthcare launches generic favipiravir tablets for COVID-19 treatment
"We hope the availability of an effective treatment such as Favijaj will considerably ease the pressure and offer patients much-needed and timely therapy options," Bajaj Healthcare Joint MD Anil Jain said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Pfizer seeks quicker nod for vaccine, donates $70 million worth of drugs
The Indian government had last month allowed emergency use approval for imported vaccines which have been granted similar approvals by the regulators in the US, UK, Europe and Japan. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Pfizer seeks quicker nod for vaccine, donates drugs worth $70 million
The Indian government had last month allowed emergency use approval for imported vaccines which have been granted similar approvals by the regulators in the US, UK, Europe and Japan. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Vaccine manufacturing a specialised process, cannot ramp up production overnight: SII's Adar Poonawalla
Poonawalla, who is in London, however, noted that the company is making every effort to enhance production of Covishield amid the second wave of COVID in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

India ’s biggest Serum Vaccine order covered just 4% of people
The lack of a larger central stockpile, coupled with a devastating second wave in the country -- daily new cases surged over 400,000 on Saturday -- is now making local state governments scramble and compete with one another in placing orders with manufacturers after the federal government turned over the responsibility of procuring vaccines to them last month. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

India receives 1.25 vials of anti-viral drug Remdesivir from US
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Natco gets emergency use nod for Baricitinib to treat Covid without trials
In a statement, the Hyderabad headquartered pharma company said Baricitinib in combination with Remdesivir is used for the treatment of Covid-19 patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Glenmark Pharma launches nasal spray Ryaltris in India
Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Pfizer in talks with Indian govt to allow use of its Covid vaccine
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Pfizer donates USD 70 mn worth COVID-19 treatment drugs to India
These medicines, valued at more than USD 70 million, will be made available immediately, said company's Chairman. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Discussions on with Indian govt for expedited approval of COVID-19 vaccine: Pfizer
Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

SII endorses receiving Rs 1,732 crore for 11 crore doses of Covishield vaccine
The company's response came after the Health Ministry in a statement refuted allegations that it has not placed any fresh orders for the Covishield vaccine with SII. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India
The donation will have no impact on the rollout in Sweden which has decided to only administer the AstraZeneca shots to people 65 and over. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Vaccination: Centre says 122 crore doses needed to inoculate 59 crore people in 18-45 age group
Stating that the central government has already taken proactive steps for procurement of other vaccines apart from Covishield and Covaxin, the Centre told the apex court that it has fast tracked the emergency approvals for foreign produced COVID-19 Vaccines that have been granted approval in other countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2021 Category: Pharmaceuticals Source Type: news

Cap Covid-19 medicines, vax prices, issue compulsory license to scale up output: RSS-affiliate SJM to govt
“Introduction of the competition is the best way to lower the prices. Patent protection is the major barrier to the generic production of these medicines,” SJM said in a statement Sunday, proposing the government to use the public health safeguards in the Patents Act and permit more companies to produce these medicines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2021 Category: Pharmaceuticals Source Type: news

COVID-19: Taiwan delivers medical supplies to India
"To express strong friendship with India in its fight against a new wave of Covid-19 pandemic, Taiwan is delivering critical medical supplies to India. The first batch of 150 oxygen concentrators and 500 oxygen cylinders have arrived in New Delhi on Sunday," the TECC said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2021 Category: Pharmaceuticals Source Type: news

Biocon Biologics provided 7,000 doses of Itolizumab in April
The company does not look at Covid-19 related drugs as a business opportunity; it expects higher growth this fiscal year on the back of new biosimilar launches in both emerging and developed markets, Arun Chandavarkar, managing director of Biocon Biologics, told ET in an interview. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2021 Category: Pharmaceuticals Source Type: news

Will return to India in a few days, says Serum Institute's Adar Poonawalla
"I'm staying here (London) for an extended time because I don't want to go back to that situation. Everything falls on my shoulders but I can't do it alone...I don't want to be in a situation where you are just trying to do your job, and just because you can't supply the needs of X, Y or Z you really don't want to guess what they are going to do," Poonawalla had told The Times. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2021 Category: Pharmaceuticals Source Type: news

Covishield production in full swing in Pune, says Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla has said that the production of COVID-19 vaccine Covishield is in full swing in Pune and he will review the operations once he is back in the country. Poonawalla is currently in the UK to meet his family members. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2021 Category: Pharmaceuticals Source Type: news

Crisis over shortage of Remdesivir, Fabiflu to end by next fortnight
"An unprecedented surge in demand of some crucial medicines, used in treating Covid patients, has created a mess. Now companies like Cipla or Cadila, and others have increased production of vials manifolds. We promise supplies will be sufficient, "Rajiv Singhal, General Secretary of All India Organisation of Chemists and Druggists(AIOCD), representing over 9.50 lakh chemists across the country, told IANS. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 1, 2021 Category: Pharmaceuticals Source Type: news

COVID-19: HMD to recruit 500 people to increase syringe production capacity
"We currently have extreme shortages of manpower. To reach our target of 100 crore syringes capacity, HMD needs to strengthen our team and employ 3,200 people but currently have on roll 2,700. We are 500 people short to achieve our target of 100 crore pcs of AD syringes by June this year," HMD MD Rajiv Nath said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 1, 2021 Category: Pharmaceuticals Source Type: news

1st batch of Russian Sputnik V vaccine arrives in India
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 1, 2021 Category: Pharmaceuticals Source Type: news

A big part of Sputnik V vaccine to be produced in India: Kirill Dmitriev, CEO, RDIF
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 1, 2021 Category: Pharmaceuticals Source Type: news

Chinese carrier Sichuan Airlines stopping flights may hit pharma imports, says industry
Citing that the decision by the Chinese owned airlines suspending its cargo services to India for 15 days "worrisome", the Indian Drug Manufacturers' Association (IDMA) has written to the external affairs ministry to intervene. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 1, 2021 Category: Pharmaceuticals Source Type: news

Government to import 4.5 lakh vials of antiviral drug Remdesivir
Demand for Remdesivir has gone up manifold in the country with a surge in COVID-19 cases. The antiviral drug is used in the treatment of the infectious disease. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 30, 2021 Category: Pharmaceuticals Source Type: news

Covid crisis: Centre announces import of 4.5 lakh vials of Remdesivir
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 30, 2021 Category: Pharmaceuticals Source Type: news

Hospitals and nursing homes look to hire more contractual workers to manage the surge in Covid-19 patients
Leading staffing and services firms such as SIS, TeamLease and Quess said requests for workers in the healthcare sector have increased sharply in the past couple of months as the second wave of Covid-19 has gripped the nation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 30, 2021 Category: Pharmaceuticals Source Type: news

India urges China to clear bottlenecks on key pharma raw-material
The Pharmexcil director-general Ravi Uday Bhaskar wrote to Indian Ambassador in China Vikram Misri for an immediate intervention in the backdrop of the decision of the Chinese state-owned Sichuan Airlines to suspend its cargo services to India for 15 days following the second wave of Covid-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 29, 2021 Category: Pharmaceuticals Source Type: news

Bharat Bio slashes Covid-19 prices by a third to states
Serum Institute of India (SII) had on Wednesday slashed the price of its COVID-19 vaccine 'Covishield' to Rs 300 per dose from the earlier Rs 400 for state governments. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 29, 2021 Category: Pharmaceuticals Source Type: news

After Covishield, Covaxin price slashed, Bharat Biotech to sell vaccine to state governments at Rs 400 per dose
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 29, 2021 Category: Pharmaceuticals Source Type: news

India approaches Egypt, UAE, Uzbekistan, Bangladesh for Remdesivir
Faced with an acute shortage of the antiviral drug, India had earlier this month waived import duty on import of Remdesivir and the raw materials used to manufacture it. Official sources here described as a diplomatic victory Remdesivir owner Gilead's decision to donate 450 vials of the drug and also provide raw materials for ramping up local production. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 29, 2021 Category: Pharmaceuticals Source Type: news

Past COVID-19 infection does not fully protect young people against reinfection: Lancet
In the study, conducted between May and November 2020, around 10 per cent or 19 out of 189 participants who were previously infected with SARS-CoV-2 (seropositive) became reinfected. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 29, 2021 Category: Pharmaceuticals Source Type: news

India will need 5 lakh ICU beds, 3.5 lakh medical staff in next few weeks, says leading surgeon
At present, India has only 75,000 to 90,000 ICU beds and almost all are already occupied - when the second wave of the pandemic hasn't even reached its peak yet, noted surgeon Dr Devi Prasad Shetty said. India is reporting about 3.5 lakh cases a day, and some experts say the number could go up to 5 lakh cases daily at its peak. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 29, 2021 Category: Pharmaceuticals Source Type: news

Covaxin found to neutralise 617 variant of COVID-19: Dr Fauci
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3. Trial results later showed the vaccine has an efficacy of 78 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Covaxin found to neutralise 617 variant of COVID-19: America's top pandemic expert Dr Fauci
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3. Trial results later showed the vaccine has an efficacy of 78 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

MSD in talks with Medicines Patent Pool for additional licenses for molnupiravir
MSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy ’s, Emcure and Hetero for molnupiravir, an experimental drug that is currently tested to treat Covid-19 infections. Merck is running the clinical trials for molnupiravir with its partner Ridgeback Biotherapeutics. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study
The researchers from King's College London in the UK also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

BioNTech co-founder 'confident' vaccine works against Indian variant
"We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident," said BioNTech co-founder Ugur Sahin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Covishield price for states slashed from Rs 400 to Rs 300 per dose: Adar Poonawalla
The SII, which is India's largest vaccine manufacturer, had earlier priced Covishield at Rs 400 per dose for the state governments and Rs 600 for the private hospitals. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Chinese companies considers mixing vaccines, booster shots
Sinovac and Sinopharm, the two Chinese manufacturers that combined have exported hundreds of millions of doses all over the world, say they're are considering combining their vaccines with those from other companies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Govt makes interim allocation of COVID-19 treatment drug tocilizumab to states
In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in COVID-19 cases in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Prices of COVID devices shoot up despite cap
Prices of oxygen concentrators, oximeters and nebulisers have surged 50-100% over the past ten days, with a huge demand-supply mismatch amid the second wave of the coronavirus pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 28, 2021 Category: Pharmaceuticals Source Type: news